Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Udagawa

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Immunology|August 1, 1985
Immunohistochemical localization of murine alpha 1-pregnancy-associated protein (alpha 1-PAP) in non-pregnant females: a comparative study with human pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG)Y Udagawa, S S Armstrong, G T Waites, et al.
Journal of Reproductive Immunology|November 1, 1985
Immunohistochemical localization of murine alpha 1-pregnancy-associated protein (alpha 1-PAP) in pregnant mice: relationship between serum alpha 1-PAP levels and incidence of positive cellsG T Waites, Y Udagawa, S S Armstrong, et al.
Cancer Research|February 1, 1990
Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinomaS Nozawa, M Yajima, T Sakuma, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 15, 1990
Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies--with special reference to the combination of PLAP and CA54/61 assayS Nozawa, Y Udagawa, H Ohkura, et al.
Anticancer Research|August 6, 2000
Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamideS Ohie, Y Udagawa, A Kozu, et al.
Nihon Sanka Fujinka Gakkai Zasshi|June 1, 1987
[Establishment and characteristics of a new human choriocarcinoma cell line and its production of tumor markers]S Nozawa, Y Udagawa, M Sakayori, et al.
Human Cell|March 1, 1990
[Establishment and characterization of a human chorionic gonadotropin (hCG) producing cell line (RTSG) from an ovarian epithelial cancer]Y Udagawa, S Nozawa, K Chin, et al.
Molecular Human Reproduction|December 17, 2010
A rare synaptonemal complex protein 3 gene variant in unexplained female infertilityS Nishiyama, T Kishi, T Kato, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2005
Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical responseS Nakada, D Aoki, S Ohie, et al.
Placenta|September 12, 2012
Upregulation of HtrA4 in the placentas of patients with severe pre-eclampsiaA Inagaki, H Nishizawa, S Ota, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Immunology|August 1, 1985
Immunohistochemical localization of murine alpha 1-pregnancy-associated protein (alpha 1-PAP) in non-pregnant females: a comparative study with human pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG)Y Udagawa, S S Armstrong, G T Waites, et al.
Journal of Reproductive Immunology|November 1, 1985
Immunohistochemical localization of murine alpha 1-pregnancy-associated protein (alpha 1-PAP) in pregnant mice: relationship between serum alpha 1-PAP levels and incidence of positive cellsG T Waites, Y Udagawa, S S Armstrong, et al.
Cancer Research|February 1, 1990
Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinomaS Nozawa, M Yajima, T Sakuma, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 15, 1990
Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies--with special reference to the combination of PLAP and CA54/61 assayS Nozawa, Y Udagawa, H Ohkura, et al.
Anticancer Research|August 6, 2000
Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamideS Ohie, Y Udagawa, A Kozu, et al.
Nihon Sanka Fujinka Gakkai Zasshi|June 1, 1987
[Establishment and characteristics of a new human choriocarcinoma cell line and its production of tumor markers]S Nozawa, Y Udagawa, M Sakayori, et al.
Human Cell|March 1, 1990
[Establishment and characterization of a human chorionic gonadotropin (hCG) producing cell line (RTSG) from an ovarian epithelial cancer]Y Udagawa, S Nozawa, K Chin, et al.
Molecular Human Reproduction|December 17, 2010
A rare synaptonemal complex protein 3 gene variant in unexplained female infertilityS Nishiyama, T Kishi, T Kato, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2005
Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical responseS Nakada, D Aoki, S Ohie, et al.
Placenta|September 12, 2012
Upregulation of HtrA4 in the placentas of patients with severe pre-eclampsiaA Inagaki, H Nishizawa, S Ota, et al.
Pageof 8